Arnicolide D, a sesquiterpene lactone isolated from Centipeda minima, has recently been shown to exert anti-tumor activity against triple-negative breast cancer cells by inhibiting the activation of Akt/mTOR and STAT3 signaling pathways [221]. This evidence concerns the gene MTOR and triple-negative breast carcinoma.